{"id":981948,"date":"2026-07-15T16:10:15","date_gmt":"2026-07-15T20:10:15","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/maxcyte-to-report-second-quarter-2026-financial-results-on-august-12-2026\/"},"modified":"2026-07-15T16:10:15","modified_gmt":"2026-07-15T20:10:15","slug":"maxcyte-to-report-second-quarter-2026-financial-results-on-august-12-2026","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/maxcyte-to-report-second-quarter-2026-financial-results-on-august-12-2026\/","title":{"rendered":"MaxCyte to Report Second Quarter 2026 Financial Results on August 12, 2026"},"content":{"rendered":"<div class=\"mw_release\">\n<p>ROCKVILLE, Md., July  15, 2026  (GLOBE NEWSWIRE) &#8212; MaxCyte, Inc., (NASDAQ: MXCT), a leading, cell-engineering focused company providing enabling platform technologies to advance the discovery, development and commercialization of next-generation cell therapeutics, today announced that it will release financial results for the second quarter 2026 after the U.S. market close on Wednesday, August 12<sup>th<\/sup>, 2026. Company management will host a conference call to discuss financial results at 4:30 p.m. Eastern Time.<\/p>\n<p>\n        <strong>Earnings Conference Call Details<\/strong><br \/>\n        <br \/>Investors interested in listening to the conference call are required to <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=synWp1E7f5b9qkEqL86BSmb0cGDRmrD3UzZrpg3fhwF0sS7QjopifR6_01eZQndsx6aL7pa9gnwSaElAi1uumPyVWzR8_Pd2OhFZaK8eYncJqXvKvB4wk5mvVLnQIDrJlOp1r2u6DEAT1-34YHQdO34SzxWJlkj8jtcv7Ln3jbw=\" rel=\"nofollow\" target=\"_blank\">register online<\/a>. It is recommended to register at least a day in advance. A live and archived webcast of the event will be available on the \u201cEvents\u201d section of the MaxCyte website at <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=5wnX5jgYQH31pqqij8rkQvuxh85hvlJzk6wFLvjti3Ysu9nQKCZoeaUmq6mRHylIUsanmhScdjbt6IoqFV1zCkd5VFT-NkwPHynotqKvGqgRC1qUT8cDp9ucFmu_oZUb\" rel=\"nofollow\" target=\"_blank\">https:\/\/investors.maxcyte.com\/<\/a>.<\/p>\n<p>\n        <strong>About MaxCyte<\/strong><\/p>\n<p>At MaxCyte<sup>\u00ae<\/sup>, we are committed to building better cells together. As a leading cell-engineering company, we are driving the discovery, development and commercialization of next-generation cell therapies. Our best-in-class Flow Electroporation<sup>\u00ae<\/sup> technology and SeQure\u2122 gene editing risk assessment services enable high-performance cell engineering and rigorous evaluation of editing outcomes, supporting confidence in therapeutic development. Supported by expert scientific, technical and regulatory guidance, our platform empowers researchers to engineer diverse cell types and payloads, accelerating the development of safe and effective treatments for human health. For more than 25 years, we\u2019ve been advancing cell engineering, shaping the future of medicine. <\/p>\n<p>Learn more at <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=nGVCdSE7gbdx5jGBV5Sf1QUl9ko4E46x3a72bGu0qEDsAdRsnq-4P4ymfJZ09FxU62u3ZyuWxTUzRY4VMl2Z0Q==\" rel=\"nofollow\" target=\"_blank\">maxcyte.com<\/a>\u00a0and follow us on\u00a0<a href=\"https:\/\/www.globenewswire.com\/Tracker?data=zLKqYYKDLa7ijXnJqp5vxewvt3HPlb1uQGZcqpTT1i7pAvAa6CqtQFZe0yxXoNEOXyUKXIUpyiKh43cviDINig9_wXkpmf85uVMgf8hclAQ=\" rel=\"nofollow\" target=\"_blank\">LinkedIn<\/a>\u00a0and\u00a0<a href=\"https:\/\/www.globenewswire.com\/Tracker?data=6SqfkEmYd81Q-NNVt30v72OM948teXwvk2Uk2N1EYj8jVDAUU0K2lJeJm3HPnI2x9GVyifLxEP6K8F5HurveBQog3s-F5MBsZn4QS31vO9o=\" rel=\"nofollow\" target=\"_blank\">Bluesky<\/a>.<\/p>\n<p>\n        <strong>Investor Relations<\/strong><br \/>\n        <br \/>\n        <strong><br \/>\n          <em>Gilmartin Group<\/em><br \/>\n        <\/strong><br \/>\n        <br \/>Erik Abdow<br \/><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=OEUyTDjUVbaFCxYysQmeJDc54SmYmWLiquQ9leuY29s43nyiv3ILXC8KyCEcxqTU7pHlipysXhdWqSRNwctW9Q==\" rel=\"nofollow\" target=\"_blank\">ir@maxcyte.com<\/a><\/p>\n<p>\n        <strong>Media Relations<\/strong><br \/>\n        <br \/>\n        <strong><br \/>\n          <em>Oak Street Communications<\/em><br \/>\n        <\/strong><br \/>\n        <br \/>Kristen White<br \/>+1 415-608-6060<br \/><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=f3nOhIbaRRMM5XYWFFp_vu5LCg7dF-XGIJoSTZRJ6n0ipmU171JDyiqI9Bv0KFABC-RzXOCrcLS77LlX0gtYs4uZPnneM7hDvtwIFhM0zecTMB92hphTiIxwUoFPgmEM2yf4f1IArSfEydRZKvIz4w==\" rel=\"nofollow\" target=\"_blank\">kristen@oakstreetcommunications.com<\/a><\/p>\n<p>      <img decoding=\"async\" alt=\"\" class=\"__GNW8366DE3E__IMG\" src=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTc2MjkzMyM3NzA4MjY0IzIyMDUxNzg=\" \/><br \/>\n      <br \/>\n      <img decoding=\"async\" alt=\"\" src=\"https:\/\/ml.globenewswire.com\/media\/NDQwNjQ2YWQtYTQyMS00NjA0LThkMTMtYWZhNjBjZTgyYjBlLTEyMTY3MzEtMjAyNi0wNy0xNS1lbg==\/tiny\/MaxCyte-Inc.png\" \/>\n    <\/div>\n<div class=\"mw_contactinfo\"><\/div>\n","protected":false},"excerpt":{"rendered":"<p>ROCKVILLE, Md., July 15, 2026 (GLOBE NEWSWIRE) &#8212; MaxCyte, Inc., (NASDAQ: MXCT), a leading, cell-engineering focused company providing enabling platform technologies to advance the discovery, development and commercialization of next-generation cell therapeutics, today announced that it will release financial results for the second quarter 2026 after the U.S. market close on Wednesday, August 12th, 2026. Company management will host a conference call to discuss financial results at 4:30 p.m. Eastern Time. Earnings Conference Call Details Investors interested in listening to the conference call are required to register online. It is recommended to register at least a day in advance. A live and archived webcast of the event will be available on the \u201cEvents\u201d section of the MaxCyte website at https:\/\/investors.maxcyte.com\/. &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/maxcyte-to-report-second-quarter-2026-financial-results-on-august-12-2026\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;MaxCyte to Report Second Quarter 2026 Financial Results on August 12, 2026&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-981948","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v28.0 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>MaxCyte to Report Second Quarter 2026 Financial Results on August 12, 2026 - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/maxcyte-to-report-second-quarter-2026-financial-results-on-august-12-2026\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"MaxCyte to Report Second Quarter 2026 Financial Results on August 12, 2026 - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"ROCKVILLE, Md., July 15, 2026 (GLOBE NEWSWIRE) &#8212; MaxCyte, Inc., (NASDAQ: MXCT), a leading, cell-engineering focused company providing enabling platform technologies to advance the discovery, development and commercialization of next-generation cell therapeutics, today announced that it will release financial results for the second quarter 2026 after the U.S. market close on Wednesday, August 12th, 2026. Company management will host a conference call to discuss financial results at 4:30 p.m. Eastern Time. Earnings Conference Call Details Investors interested in listening to the conference call are required to register online. It is recommended to register at least a day in advance. A live and archived webcast of the event will be available on the \u201cEvents\u201d section of the MaxCyte website at https:\/\/investors.maxcyte.com\/. &hellip; Continue reading &quot;MaxCyte to Report Second Quarter 2026 Financial Results on August 12, 2026&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/maxcyte-to-report-second-quarter-2026-financial-results-on-august-12-2026\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2026-07-15T20:10:15+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTc2MjkzMyM3NzA4MjY0IzIyMDUxNzg=\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/maxcyte-to-report-second-quarter-2026-financial-results-on-august-12-2026\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/maxcyte-to-report-second-quarter-2026-financial-results-on-august-12-2026\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"MaxCyte to Report Second Quarter 2026 Financial Results on August 12, 2026\",\"datePublished\":\"2026-07-15T20:10:15+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/maxcyte-to-report-second-quarter-2026-financial-results-on-august-12-2026\\\/\"},\"wordCount\":263,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/maxcyte-to-report-second-quarter-2026-financial-results-on-august-12-2026\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTc2MjkzMyM3NzA4MjY0IzIyMDUxNzg=\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/maxcyte-to-report-second-quarter-2026-financial-results-on-august-12-2026\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/maxcyte-to-report-second-quarter-2026-financial-results-on-august-12-2026\\\/\",\"name\":\"MaxCyte to Report Second Quarter 2026 Financial Results on August 12, 2026 - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/maxcyte-to-report-second-quarter-2026-financial-results-on-august-12-2026\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/maxcyte-to-report-second-quarter-2026-financial-results-on-august-12-2026\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTc2MjkzMyM3NzA4MjY0IzIyMDUxNzg=\",\"datePublished\":\"2026-07-15T20:10:15+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/maxcyte-to-report-second-quarter-2026-financial-results-on-august-12-2026\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/maxcyte-to-report-second-quarter-2026-financial-results-on-august-12-2026\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/maxcyte-to-report-second-quarter-2026-financial-results-on-august-12-2026\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTc2MjkzMyM3NzA4MjY0IzIyMDUxNzg=\",\"contentUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTc2MjkzMyM3NzA4MjY0IzIyMDUxNzg=\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/maxcyte-to-report-second-quarter-2026-financial-results-on-august-12-2026\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"MaxCyte to Report Second Quarter 2026 Financial Results on August 12, 2026\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"MaxCyte to Report Second Quarter 2026 Financial Results on August 12, 2026 - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/maxcyte-to-report-second-quarter-2026-financial-results-on-august-12-2026\/","og_locale":"en_US","og_type":"article","og_title":"MaxCyte to Report Second Quarter 2026 Financial Results on August 12, 2026 - Market Newsdesk","og_description":"ROCKVILLE, Md., July 15, 2026 (GLOBE NEWSWIRE) &#8212; MaxCyte, Inc., (NASDAQ: MXCT), a leading, cell-engineering focused company providing enabling platform technologies to advance the discovery, development and commercialization of next-generation cell therapeutics, today announced that it will release financial results for the second quarter 2026 after the U.S. market close on Wednesday, August 12th, 2026. Company management will host a conference call to discuss financial results at 4:30 p.m. Eastern Time. Earnings Conference Call Details Investors interested in listening to the conference call are required to register online. It is recommended to register at least a day in advance. A live and archived webcast of the event will be available on the \u201cEvents\u201d section of the MaxCyte website at https:\/\/investors.maxcyte.com\/. &hellip; Continue reading \"MaxCyte to Report Second Quarter 2026 Financial Results on August 12, 2026\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/maxcyte-to-report-second-quarter-2026-financial-results-on-august-12-2026\/","og_site_name":"Market Newsdesk","article_published_time":"2026-07-15T20:10:15+00:00","og_image":[{"url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTc2MjkzMyM3NzA4MjY0IzIyMDUxNzg=","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/maxcyte-to-report-second-quarter-2026-financial-results-on-august-12-2026\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/maxcyte-to-report-second-quarter-2026-financial-results-on-august-12-2026\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"MaxCyte to Report Second Quarter 2026 Financial Results on August 12, 2026","datePublished":"2026-07-15T20:10:15+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/maxcyte-to-report-second-quarter-2026-financial-results-on-august-12-2026\/"},"wordCount":263,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/maxcyte-to-report-second-quarter-2026-financial-results-on-august-12-2026\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTc2MjkzMyM3NzA4MjY0IzIyMDUxNzg=","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/maxcyte-to-report-second-quarter-2026-financial-results-on-august-12-2026\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/maxcyte-to-report-second-quarter-2026-financial-results-on-august-12-2026\/","name":"MaxCyte to Report Second Quarter 2026 Financial Results on August 12, 2026 - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/maxcyte-to-report-second-quarter-2026-financial-results-on-august-12-2026\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/maxcyte-to-report-second-quarter-2026-financial-results-on-august-12-2026\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTc2MjkzMyM3NzA4MjY0IzIyMDUxNzg=","datePublished":"2026-07-15T20:10:15+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/maxcyte-to-report-second-quarter-2026-financial-results-on-august-12-2026\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/maxcyte-to-report-second-quarter-2026-financial-results-on-august-12-2026\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/maxcyte-to-report-second-quarter-2026-financial-results-on-august-12-2026\/#primaryimage","url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTc2MjkzMyM3NzA4MjY0IzIyMDUxNzg=","contentUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTc2MjkzMyM3NzA4MjY0IzIyMDUxNzg="},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/maxcyte-to-report-second-quarter-2026-financial-results-on-august-12-2026\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"MaxCyte to Report Second Quarter 2026 Financial Results on August 12, 2026"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/981948","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=981948"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/981948\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=981948"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=981948"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=981948"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}